Teva Pharmaceutical Industries Ltd. - Company & Market Research Reports

Home /
Companies /
Teva Pharmaceutical Industries Ltd.

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 312
Cardiovascular Drugs 200
Infectious Diseases Drugs 200
Oncology Drugs 172
Analgesics 168
Respiratory Drugs 168
Immune Disorders Drugs 164
Musculoskeletal Disorders Drugs 157
Gastrointestinal Drugs 145
Infusions and Injectables 135
Endocrine and Metabolic Disorders Drugs 132
Sexual and Reproductive Health Drugs 130
Generic Drugs 112
Antibiotics 102
Over the Counter (OTC) Drugs 97
Pharmaceuticals 94
Drug Delivery 71
Urological Disorders Drugs 68
Inhalers and Nebulisers 65
Pharmaceutical Intermediates 60
Biopharmaceuticals 60
Mental Disorders Drugs 59
Dermatological Drugs 57
Animal Pharmaceuticals 56
Biosimilars and Biosuperiors 56
Transdermal and Transmucosal Drug Delivery 54
Hematological Drugs 52
Liver and Kidney Disorders Drugs 51
Leukemia Drugs 50
Asthma Drugs 49
Optical Disorders Drugs 48
Lung Cancer Drugs 48
Breast Cancer Drugs 45
Clinical Trials 38
Allergy Drugs 35
Immunosuppressive Drugs 34
Addiction Disorders Drugs 33
Drug Discovery 33
Anxiety Drugs 31
Anesthetic Drugs 30
Diabetes Drugs 29
Ovarian Cancer Drugs 28
Bronchitis Drugs 28
Pancreatic Cancer Drugs 27
Acne Drugs 27
Psoriasis Drugs 26
Drugs by Therapeutic Area 25
Pharmaceutical Manufacturing 25
Brain Cancer Drugs 24
Cough and Cold Drugs 24
HIV/AIDS Drugs 24
Prostate Cancer Drugs 23
Lymphoma Drugs 23
Vitamins and Dietary Supplements 22
Alzheimer's Disease Drugs 22
Skin Cancer Drugs 21
Thyroid Cancer Drugs 21
Schizophrenia Drugs 19
Colon Cancer Drugs 18
Bladder Cancer Drugs 16
Liver Cancer Drugs 15
Kidney Cancer Drugs 14
Cervical Cancer Drugs 11
Anti-Obesity Drugs 9
Vaccines 8
Company Reports 4
Uterine Cancer Drugs 4
Pharmacoeconomics 1
Cancer Vaccines 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

3,010 Results (Page 80 of 151)
- Relevance
  Sort by

Europe Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023-2029

 Report
April 2023
128 Pages
Europe

From

€1334EUR$1,500USD£1,154GBP

LAMEA Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023-2029

 Report
April 2023
129 Pages
Africa, Middle East

From

€1334EUR$1,500USD£1,154GBP

Asia Pacific Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023-2029

 Report
April 2023
128 Pages
Asia Pacific

From

€1334EUR$1,500USD£1,154GBP

North America Gastric Cancer Market Size, Share & Industry Trends Analysis Report By Route of Administration (Injectable and Oral), By Treatment Type, By Disease Type, By Distribution Channel, By Drug Class, By Country and Growth Forecast, 2023-2029

 Report
April 2023
112 Pages
North America

From

€1334EUR$1,500USD£1,154GBP

Anti-Retroviral Drugs Market - Growth, Trends, COVID-19 and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4226EUR$4,750USD£3,654GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021

 Clinical Trials
December 2021
283 Pages
Global

From

€2224EUR$2,500USD£1,923GBP

Motion Sickness Drugs Market 2024-2028

 Report
June 2024
169 Pages
Global

From

€2224EUR$2,500USD£1,923GBP

Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032

 Report
January 2026
193 Pages
Global

From

€3154EUR$3,545USD£2,727GBP

€3504EUR$3,939USD£3,030GBP

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy, Surgery), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Achilles Tendonitis), By Region (North America, Europe), And Segment Forecasts, 2025 - 2030

 Report
November 2024
150 Pages
Global

From

€5293EUR$5,950USD£4,577GBP

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report by Drug Class, Type (Branded, Generics), Route of Administration (Oral, Intravenous/Subcutaneous, Inhalational) and Region with Growth Forecasts, 2025-2033

 Report
November 2025
150 Pages
Global

From

€5293EUR$5,950USD£4,577GBP

Amlodipine Besylate - Global Strategic Business Report

 Report
June 2026
177 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Pericarditis Drugs - Global Strategic Business Report

 Report
June 2026
289 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Critical Limb Ischemia Treatment - Global Strategic Business Report

 Report
June 2026
375 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Telmisartan Market - Global Strategic Business Report

 Report
June 2026
477 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Losartan Market - Global Strategic Business Report

 Report
June 2026
384 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Orthostatic Hypotension Drugs - Global Strategic Business Report

 Report
June 2026
286 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Hemorrhagic Stroke Drugs - Global Strategic Business Report

 Report
June 2026
287 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Atherosclerosis Drugs - Global Strategic Business Report

 Report
June 2026
389 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Lisinopril - Global Strategic Business Report

 Report
June 2026
476 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

Long QT Syndrome Treatment - Global Strategic Business Report

 Report
June 2026
277 Pages
Global

From

€5204EUR$5,850USD£4,500GBP

3,010 Results (Page 80 of 151)
- 1
- 78
- 79
- 80
- 81
- 82

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.